Singh Manmeet Soni - COO and CFO, Reata Pharmaceuticals Inc

As of January 6, 2021


Singh Manmeet Soni Net Worth

  • Net worth is estimated to be at least $7.81M
  • Owns at least 3,000 units of Reata Pharmaceuticals Inc stock

Singh Manmeet Soni Trading

  • Largest purchase of shares was 3,000 units , worth over $300.63K on August 14, 2020
  • In total has made about 4 transactions over 2 years
  • Usually trades in August and January, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Singh Manmeet Soni Mailing Address

  • Mailing address is C/o Pharmacyclics, Inc. 995 East Arques Ave Sunnyvale CA 94085 CA

Reata Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
J. Warren Huff 2020 $636,400 $413,660 - $5,000 $5,000 $6,396,130
J. Warren Huff 2019 $578,500 $600,540 - $16,715 $16,715 $5,542,605
J. Warren Huff 2018 $534,000 $400,500 - - - $934,500
Manmeet S. Soni 2020 $545,900 $445,700 - $136,125 $136,125 $4,465,894
Manmeet S. Soni 2019 $179,385 $408,873 - $70,243 $70,243 $12,261,587
Dawn C. Bir 2020 $422,000 $239,900 - $5,000 $5,000 $3,871,542
Dawn C. Bir 2019 $375,100 $287,550 - $3,500 $3,500 $1,975,899
Colin J. Meyer, M.D. 2020 $513,951 $381,400 - - - $4,233,520
Colin J. Meyer, M.D. 2019 $445,600 $389,467 - - - $2,182,780
Colin J. Meyer, M.D. 2018 $417,000 $208,500 - - - $625,500
Michael D. Wortley 2020 $421,100 $339,500 - - - $3,965,242
Michael D. Wortley 2019 $382,800 $341,400 - - - $2,033,949
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1358762/000156459021022192/reta-def14a_20210610.htm

Reata Pharmaceuticals Inc Insider Trading

  • The most recent transaction was 60,000 units sold on June 16, 2021 by John Colin Meyer worth over $8.55M
  • In the last 5 years, insiders at Reata Pharmaceuticals Inc sold an estimated value of $113.89M and bought an estimated value of $136.9M
  • The most active traders are Douglas Jason Wilson, Executive VP Operations,  Elaine Castellanos, VP,  and R. Kent McGaughy Jr., Director
  • Insider trading is most common in June, with the busiest year in 2019

REATA PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1